WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...
Recent data demonstrating that the clinical benefit of lowering lipoprotein(a) is proportional to the absolute reduction in its concentration should be useful for the design of future lipid-lowering ...
IN THIS issue of the Journal of Clinical Oncology, Chao et al 1 report the results of a study that examined the impact of using four different risk/benefit measures when communicating survival ...
WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...